Form Bio News and Activities
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Form Bio
- Michelle Chen, Chief Executive Officer and President
- Andrew Busey, Executive Chairman of the Board
- Linda Murray, Chief Financial Officer
Popular executive movements at Form Bio
- Brandi Cantarel, Vice President of Bioinformatics, has left the company (posted on December 23 2025).
Create your alert
to follow the executive moves at Form Bio.
Biotechnology
Form Bio has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Popular M&A news in Biotechnology
- Chemomab and Scipher Medicine have announced they will merge (posted on July 13 2026)..
- Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
- The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
Popular contacts in Biotechnology
News
Press releases by Form Bio
- Form Bio Launches FormManufacturing, an End-to-End Platform for AI-Driven Design and Manufacturing of Genetic Medicines
- Form Bio News: AI-Powered Genetic Medicine Updates
- Form Bio and Weill Cornell Medicine Announce Strategic Collaboration to Advance Gene Editing Therapy for Alzheimer's Disease
- Form Bio News: AI-Powered Genetic Medicine Updates
- Form Bio and Weill Cornell Medicine Announce Strategic Collaboration to Advance Gene Editing Therapy for Alzheimer's Disease
- Form Bio and Cure Rare Disease Partner to Accelerate Genetic Medicine Development, Advancing CRD's Duchenne Muscular Dystrophy Program
- Form Bio Appoints Michelle Chen, Ph.D. as President and Chief Executive Officer
- Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development
- News | Form Bio
- News | Form Bio
- View more press releases Close
Social media about Form Bio
- Form Bio on Wikipedia, Google News & Yahoo Finance
- Form Bio on LinkedIn, X (Twitter) & YouTube
